Legal Opinion
MD Pharmaceutical, Inc. v. Drug Enforcement Administration
Court of Appeals for the D.C. Circuit
Decided January 16, 1998No. 96-1256PublishedCited by 108 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge SENTELLE.
SENTELLE, Circuit Judge:
This ease arises out of the Drug Enforcement Administration’s (“DEA”) approval of an application submitted by Mallinckrodt Chemical, Inc. (“Mallinckrodt”) for registration as a bulk manufacturer of methylpheni-date, a generic form of the drug commonly known by the brand name of Ritalin. MD Pharmaceutical, Inc. (“MD”), a current producer of methylphenidate, petitions for review of three decisions made by DEA, namely: (1) the decision to permit withdrawal of Mallinckrodt’s two previous applications for registration as…
2Cases cited13 opinions
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Association of Data Processing Service Organizations, Inc. v. CampSupreme Court of the United States · 1970
- Heckler v. ChaneySupreme Court of the United States · 1985
- Clarke v. Securities Industry Assn.Supreme Court of the United States · 1987
8 more not listed; retrieve them via the Exa API.
3Cited by108 opinions
- Mova Pharmaceutical Corp. v. ShalalaCourt of Appeals for the D.C. Circuit · 1998
- Shays v. Federal Election CommissionCourt of Appeals for the D.C. Circuit · 2005
- LA Engy & Power Auth v. FERCCourt of Appeals for the D.C. Circuit · 1998
- Americans for Safe Access v. Drug Enforcement AdministrationCourt of Appeals for the D.C. Circuit · 2013
- Cox Oklahoma Telecom, LLC v. State Ex Rel. Oklahoma Corp. CommissionSupreme Court of Oklahoma · 2007
103 more not listed; retrieve them via the Exa API.